Procter & Gamble Health Limited Financial Ratios
PGHL · Healthcare · Current price ₹5,199.5
P/E ratio
26.4x
P/B ratio
17.2x
ROE
62.3%
ROCE
84.4%
Debt / Equity
0.02
Dividend yield
3.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 26.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 17.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 62.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 84.4% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.02 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Procter & Gamble Health Limited's latest numbers.
Procter & Gamble Health Limited profitability
Procter & Gamble Health Limited generates a return on equity of 62.3% and a return on capital employed of 84.4%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.02 and a P/E of 26.4x, Procter & Gamble Health Limited is conservatively financed. Our overall business-quality score for the company is 6.4 / 10.
Understand the ratios
More on Procter & Gamble Health Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.